FDA’s Push for New COVID-19 Vaccines Despite Diminished Virus Impact and Safety Concerns
The FDA's vaccine advisory committee unanimously recommended a monovalent JN.1-lineage vaccine composition for COVID-19 vaccines for 2024-2025. Dr. David Wiseman...